A detailed history of Gries Financial LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gries Financial LLC holds 9,284 shares of MRK stock, worth $894,142. This represents 0.22% of its overall portfolio holdings.

Number of Shares
9,284
Previous 9,337 0.57%
Holding current value
$894,142
Previous $1.16 Million 8.74%
% of portfolio
0.22%
Previous 0.27%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$111.15 - $128.97 $5,890 - $6,835
-53 Reduced 0.57%
9,284 $1.05 Million
Q2 2024

Aug 02, 2024

SELL
$123.8 - $132.96 $141,008 - $151,441
-1,139 Reduced 10.87%
9,337 $1.16 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $77,229 - $89,989
682 Added 6.96%
10,476 $1.38 Million
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $22,740 - $24,747
-227 Reduced 2.27%
9,794 $1.07 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $44,783 - $49,733
-435 Reduced 4.16%
10,021 $1.03 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $789,920 - $860,977
-7,273 Reduced 41.02%
10,456 $1.21 Million
Q1 2023

Jun 21, 2023

SELL
$102.94 - $114.86 $2.7 Million - $3.01 Million
-26,224 Reduced 59.66%
17,729 $1.89 Million
Q4 2022

Jan 10, 2023

BUY
$87.44 - $112.11 $889,964 - $1.14 Million
10,178 Added 30.13%
43,953 $4.88 Million
Q3 2022

Oct 31, 2022

BUY
$84.53 - $94.96 $60,523 - $67,991
716 Added 2.17%
33,775 $2.91 Million
Q2 2022

Aug 16, 2022

BUY
$83.49 - $94.64 $39,073 - $44,291
468 Added 1.44%
33,059 $3.01 Million
Q1 2022

Apr 29, 2022

BUY
$73.51 - $82.4 $1.56 Million - $1.75 Million
21,229 Added 186.84%
32,591 $2.67 Million
Q4 2021

Feb 02, 2022

BUY
$72.28 - $90.54 $20,093 - $25,170
278 Added 2.51%
11,362 $871,000
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $13,332 - $14,662
-186 Reduced 1.65%
11,084 $833,000
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $776,052 - $914,109
11,270 New
11,270 $887,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Gries Financial LLC Portfolio

Follow Gries Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gries Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gries Financial LLC with notifications on news.